Gut microbiota‐derived synbiotic formula (SIM01) as a novel

Por um escritor misterioso

Last updated 04 março 2025

Gut microbiota‐derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID‐19: An open‐label pilot study - Zhang - 2022 - Journal of Gastroenterology and Hepatology - Wiley Online Library

Characterization of the Intestinal Microbiome in Healthy Adults over Sars-Cov-2 Vaccination

Frontiers Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection

CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

The Role of the Gut-Lung Axis in COVID-19 Infections and Its Modulation to Improve Clinical Outcomes

Synbiotic formula shows promise in reducing long COVID symptoms

Probiotics for immunomodulation in prevention against respiratory viral infections with special emphasis on COVID-19

A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial - The Lancet Infectious Diseases

The association between macronutrient intakes and coronavirus disease 2019 (COVID-19) in an Iranian population: applying a dynamical system model, Journal of Health, Population and Nutrition

2′-Fucosyllactose Promotes the Production of Short-Chain Fatty Acids and Improves Immune Function in Human-Microbiota-Associated Mice by Regulating Gut Microbiota

Recomendado para você